Screener
Ironwood Pharmaceuticals IRWD Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Ironwood Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: Ironwood Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091987
FAQ
- What is Ironwood Pharmaceuticals's asset turnover?
- Ironwood Pharmaceuticals (IRWD) reported asset turnover of 1.2× in Q2 2026.
- How has Ironwood Pharmaceuticals's asset turnover changed year-over-year?
- Ironwood Pharmaceuticals's asset turnover increased by 48.4% year-over-year, from 0.8× to 1.2×.
- What is the long-term trend for Ironwood Pharmaceuticals's asset turnover?
- Over 5 years (2020 to 2025), Ironwood Pharmaceuticals's asset turnover has grown at a -0.4% compound annual growth rate (CAGR), from 0.8× to 0.8×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about Ironwood Pharmaceuticals's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude